New Treatment Approach for Alzheimer’s Disease
Research looking at a possible new therapeutic approach for Alzheimer’s disease was recently published in the Journal of Neuroinflammation. The work looked at targeting inflammation by using an antibody. Alzheimer’s disease and related dementias have no disease-modifying treatments at this time and represent a looming public health crisis given the continually growing aging population.
The paper by researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is titled, “Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition”.
Release date: 25 August 2020
Source: University of Kentucky